Navigation Links
Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
Date:8/18/2010

NEW YORK, Aug. 18 /PRNewswire-FirstCall/ -- Regenicin, Inc. (OTC Bulletin Board: WDSTD), a development stage biotechnology company, announced today that it has completed an initial $3.25 million funding in conjunction with its acquisition of a worldwide exclusive license to know-how technology controlled by Lonza Walkersville ("Lonza Agreement").  Lonza Walkersville is a subsidiary of Lonza Group Ltd. (SIX: LONN), one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries and the largest cell therapy manufacturer in the world.

The Lonza Agreement provides Regenicin with the worldwide marketing rights to a proprietary tissue-engineered skin substitute technology intended to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures.  Regenicin's management team intends to use its expertise, with the assistance of Lonza Walkersville, to further enhance its capabilities and seek approval by the U.S. Food and Drug Administration for commercial sale. Regenicin plans to seek marketing approval for this revolutionary product throughout the world under the brand name PermaDerm™.  

Pursuant to the Lonza Agreement, Lonza will retain exclusive manufacturing rights for PermaDerm™ products.  Additionally, a license to the patent rights and related key intellectual property comprising the technology, developed at the University of California, University of Colorado, the University of Cincinnati and Shriners Hospitals for Children, may be acquired by Regenicin if FDA approval is obtained.

Regenicin secured the initial financing through a combination of convertible loans and a private placement of its common stock with several major institutions and accredited investors. NewOak Capital, Inc. and Smith Point, Ltd. acted as co-p
'/>"/>

SOURCE Regenicin, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management
2. Resverlogix Completes Dosing for ASSERT Trial
3. Xybion Completes Acquisition of Stelex and Vital-Path, Leaders in Business Process Software and Consulting Services for Regulated Industries, from GE Healthcare
4. Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study
5. Hendrick Construction Completes Oak Ridge National Laboratory Expansion
6. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
7. Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S.
8. NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico
9. EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
10. APT Pharmaceuticals Completes Enrollment in Phase III for Inhaled Cyclosporine
11. Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... ... applications such as animal waste reduction, bioremediation, wastewater treatment, aquaculture and grease, ... announced today that it will be showcasing, ManureMagic™, its industry-leading product for ...
(Date:7/3/2015)... , July 3, 2015 /PRNewswire/ ... hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Innovation in Science" -jatkokoulutusohjelmaan 22.7.2015 ... Gesellschaftin (LBG) tekemän, kansainvälisiä tutkijoita ... terveystieteiden kaksi suurinta haastetta ovat ...
(Date:7/3/2015)... ... July 03, 2015 , ... The ... companies and professional service industries alike-- typically known for its consummate professionalism-- embarks ... a good cause and break from their day jobs. , "Our motto has ...
(Date:7/3/2015)... ... July 03, 2015 , ... The global failure analysis ... from 2015 to 2020. The bioscience market is expected to grow at the highest ... of failure analysis equipment in the research labs and academic institutions for root cause ...
Breaking Biology Technology:DryLet to Highlight Benefits of Patented ManureMagic™ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3The Alexander Group Declares Their Independence with a Bit of Levity 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5
... Feb. 24 Today, Genencor, a division of ... of its cellulosic ethanol enzyme product. Genencor introduced ... 2009 National Ethanol Conference in San Antonio, TX.Accellerase(R) ... biofuels and other biochemicals made from cellulosic feedstocks, ...
... Lower the Cost of Genome Analysis to $100 ... for Routine Medical Care-PHILADELPHIA, Feb. 24 BioNanomatrix, ... and analysis platforms for biomedical research, molecular diagnostics ... nanofluidic genome analysis technology, along with founder and ...
... Sciences, Inc. (GNS) today announced that it has named ... Stromedix, Inc. and former Executive Vice President of Research ... Dr. Gilman has been Founder and Chief Executive Officer ... Executive Vice President, Research at Biogen Idec. He joined ...
Cached Biology Technology:Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol 2BioNanomatrix's Revolutionary Whole Genome Analysis Platform Named to MIT Technology Review's Annual 10 Emerging Technologies List 2BioNanomatrix's Revolutionary Whole Genome Analysis Platform Named to MIT Technology Review's Annual 10 Emerging Technologies List 3Gene Network Sciences Announces Michael Gilman as Board Member 2
(Date:6/24/2015)... , June 24, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that Sharp has selected ... secure authentication for its latest flagship smartphone device, ... than 200 million shipments of its fingerprint ID ... Synaptics, strength, scalability and leadership in the biometrics ...
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2
... winter for Monarch butterflies, according to Chip Taylor, director of ... low temperatures, storms and habitat destruction have all threatened the ... lot of time fretting over the status of the monarch ... will help me understand the past as a way of ...
... paper by a team of researchers led by University ... important shift in thinking about the genomics of speciation. ... appears in today,s edition of the Proceedings of ... among scientists about how the genomes of newly forming ...
... Inducing cellular immunity as a means to protect ... at the Trudeau Institute.,Researchers here have recently identified two ... might allow us to pre-position our own virus-fighting T ... In laboratories around the world, researchers are working ...
Cached Biology News:As monarch butterflies journey north, gardeners can help protect species, researcher says 2Paper offers new insights into the genomics of speciation 2Directing immune traffic -- signposts to the lung 2
... kit provides complete components including positive and ... DNA fragmentation in cultured cells and tissue ... of apoptotic cells. Internucleosomal DNA ... mammalian cells. MBLs ApoDIRECT In Situ DNA ...
SDS-OutT Precipitation Reagent...
... FLA-5000 imaging system allows scanning ... as large as 40 x ... as 25 microns. This system ... electrophoresis in the proteomics field ...
SDS-OutT SDS Precipitation Reagent...
Biology Products: